CO60 Mortality Impact Following the EU Approval of Numerous Novel Non-Small Cell Lung Cancer (NSCLC) Therapies Between 2010-2020
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.139
https://www.valueinhealthjournal.com/article/S1098-3015(22)02343-9/fulltext
Title :
CO60 Mortality Impact Following the EU Approval of Numerous Novel Non-Small Cell Lung Cancer (NSCLC) Therapies Between 2010-2020
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02343-9&doi=10.1016/j.jval.2022.09.139
First page :
Section Title :
Open access? :
No
Section Order :
10928